“With the goal of helping global patients, Alphamab Oncology is such an ambitious and dedicated innovative pharmaceutical company with fully integrated in-house R&D platform. It is a major leap in my career from an auditor in an accounting firm to a financial manager in a leading biotech company. The rapid growth of the company has provided me with a broad career development platform, and the merit-based and efficient corporate culture has been an excellent fit for me. I will grow with the company and contribute to the company’s mission to enable more patients in the world to get access to innovative medicine to treat their diseases. A Better You, A Better World.”

“I am very honored to join the company when its self-developed innovative PD-L1/CTLA-4 bispecific antibody (KN046) entered clinical trials in China. As the first CRA of this project, I deeply felt the responsibility and honor, and every process and details was personally worked out and re-examined to lay a good foundation for future projects and colleagues. When I encounter any problems and difficulties, the company leaders and colleagues will always come first to give their support. I am confident to grow with KN046 project and the clinical team to look forward to the future.”